Alpha-arylethylpiperazine derivatives as neurokinin antagonists
The invention relates to new alpha -arylethylpiperazine derivatives, which are useful as neurokinin receptor antagonists (NK1antagonists). It also relates to processes for the preparation of said alpha -arylethylpiperazine derivatives, to their use for the prevention and/or treatment of a condition...
Saved in:
Main Authors | , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
03.07.2001
|
Edition | 7 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The invention relates to new alpha -arylethylpiperazine derivatives, which are useful as neurokinin receptor antagonists (NK1antagonists). It also relates to processes for the preparation of said alpha -arylethylpiperazine derivatives, to their use for the prevention and/or treatment of a condition associated with pathogical levels of substance P in a patient and to pharmaceutical compositions containing them. |
---|---|
AbstractList | The invention relates to new alpha -arylethylpiperazine derivatives, which are useful as neurokinin receptor antagonists (NK1antagonists). It also relates to processes for the preparation of said alpha -arylethylpiperazine derivatives, to their use for the prevention and/or treatment of a condition associated with pathogical levels of substance P in a patient and to pharmaceutical compositions containing them. |
Author | SOLO GOLDSTEIN THOMAS RYCKMANS JEAN-PIERRE HENICHART MICHEL NEUWELS FRANCOISE STIERNET MARIE-AGNES LASSOIE FLORENCE MOUREAU CHRISTOPHE GENICOT THIERRY TAVERNE |
Author_xml | – fullname: MICHEL NEUWELS – fullname: FLORENCE MOUREAU – fullname: FRANCOISE STIERNET – fullname: MARIE-AGNES LASSOIE – fullname: THOMAS RYCKMANS – fullname: SOLO GOLDSTEIN – fullname: CHRISTOPHE GENICOT – fullname: THIERRY TAVERNE – fullname: JEAN-PIERRE HENICHART |
BookMark | eNqFyj0KwkAQBtAttPDvDO4FApqAlrKI4gG0DoN-JoPL7LIzBuLpbeytXvPmbiJJMHOHEHNPFZUxwvoxZs4o9GGBf6DwQMYD1JN6wbukFwuLJzHqkrCaLt30SVGx-rlw6_PperxUyKmFZrpDYG241bt9U2-2ofk_vnINMyM |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
Edition | 7 |
ExternalDocumentID | AU2673201A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_AU2673201A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 15:21:08 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_AU2673201A3 |
Notes | Application Number: AU2673201 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20010703&DB=EPODOC&CC=AU&NR=2673201A |
ParticipantIDs | epo_espacenet_AU2673201A |
PublicationCentury | 2000 |
PublicationDate | 20010703 |
PublicationDateYYYYMMDD | 2001-07-03 |
PublicationDate_xml | – month: 07 year: 2001 text: 20010703 day: 03 |
PublicationDecade | 2000 |
PublicationYear | 2001 |
RelatedCompanies | U C B, S.A |
RelatedCompanies_xml | – name: U C B, S.A |
Score | 2.5396333 |
Snippet | The invention relates to new alpha -arylethylpiperazine derivatives, which are useful as neurokinin receptor antagonists (NK1antagonists). It also relates to... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Alpha-arylethylpiperazine derivatives as neurokinin antagonists |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20010703&DB=EPODOC&locale=&CC=AU&NR=2673201A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LS8NAEB5qFfWmVanvHCS3xbzTHEJJ86AIfSCt9Fby2NiiJCGJSv-9s2ujXnpbdmGZHebb2dmd-RbgQdZoKilJRFIrNYhmmiHpxZFOkpDfQZqGxZ8LRmNjONeeFvqiBaumFobzhH5xckREVIx4r_l-XfxdYnk8t7J6jNbYlfeDme2JTXQsMwsWvYHtTyfexBVdFyNJcfxsK4apoq9z9mAfD9EmS_7yXwasJqX471CCEziY4lxZfQotmnXgyG3-XevA4Wj73I3NLfKqM-g7rCiWhOUGFb3avBfrgpacGlpI0Ig-OX93JYSVwBkq39i_DwJqLXzNGTdudQ73gT9zhwQlWf4ueunMG5HVC2hneUa7ICSxzlAWJ5oRa-iLLapIPYZCqsaSJsuX0N01y9XuoWs4_smsMomk3kC7Lj_oLbraOrrjWvoGr86EQw |
link.rule.ids | 230,309,783,888,25578,76884 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dT8IwEL8gGvFNUYOf7MHsrXFjX_CwENhYUNkgBgxvZB-dEM22sKnhv_damfrCW9Mml-ulv17bu_sV4E5WaSy1ooDEnVgnqmH4pB0GGol8_gZp6B0eLnA9fThTH-favALLshaG84R-cXJERFSIeC_4fp39PWLZPLcyvw9W2JV2nalpi-XtWGYrWLT75mAytseWaFl4kxS9Z7OlGwr6ut4e7OMBu81Y9gcvfVaTkv13KM4xHExQVlKcQIUmdahZ5b9rdTh0t-FubG6Rl59Ct8eKYom_3qChl5v3bJXRNaeGFiJcRJ-cvzsX_FzgDJVv7N8HAa3mv6aMGzc_g6YzmFpDgposfie96M1KlZVzqCZpQhsgRKHGUBZGqh6q6Is7tCW1GQqpEkqqLF9AY5eUy91DTagNp-5oMXrwnq7g6CfLyiCScg3VYv1Bb9DtFsEtt9g3C7mHMw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Alpha-arylethylpiperazine+derivatives+as+neurokinin+antagonists&rft.inventor=MICHEL+NEUWELS&rft.inventor=FLORENCE+MOUREAU&rft.inventor=FRANCOISE+STIERNET&rft.inventor=MARIE-AGNES+LASSOIE&rft.inventor=THOMAS+RYCKMANS&rft.inventor=SOLO+GOLDSTEIN&rft.inventor=CHRISTOPHE+GENICOT&rft.inventor=THIERRY+TAVERNE&rft.inventor=JEAN-PIERRE+HENICHART&rft.date=2001-07-03&rft.externalDBID=A&rft.externalDocID=AU2673201A |